SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-243457
Filing Date
2018-08-09
Accepted
2018-08-09 07:22:55
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d892898d10q.htm 10-Q 667682
2 EX-31.1 d892898dex311.htm EX-31.1 6208
3 EX-31.2 d892898dex312.htm EX-31.2 6195
4 EX-32.1 d892898dex321.htm EX-32.1 3800
5 EX-32.2 d892898dex322.htm EX-32.2 3787
  Complete submission text file 0001193125-18-243457.txt   3144673

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20180630.xml EX-101.INS 475648
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20180630.xsd EX-101.SCH 38397
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20180630_cal.xml EX-101.CAL 49998
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20180630_def.xml EX-101.DEF 120276
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20180630_lab.xml EX-101.LAB 331183
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20180630_pre.xml EX-101.PRE 223531
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 181003173
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences